KRT18 and metabolic dysfunction-associated steatohepatitis: Biomarkers of apoptosis like Cytokeratin-18 are strongly increased in NASH patients and distinguish between simple steatosis and NASH (Wieckowska et al, 2006; Younossi et al, 2008).